Getinge sells biosurgery business to HJ Capital 1

Getinge's Atrium Medical has agreed to sell its biosurgery business, which makes soft tissue reinforcement devices, to HJ Capital 1, parent of SeCQure Surgical. The deal covers all assets and liabilities except mesh liability claims, with no material financial impact.

“Today Getinge said it agreed to sell the business, which at $14.2 million in 2017 sales (SEK 128 million) is a relatively small segment, to SeCQure parent HJ Capital 1.”massdevice.com

• 1 source
• massdevice.comGetinge's Atrium Medical deals biosurg biz to SeCQure Surgical parent - MassDeviceBrad PerrielloOct 18, 2018

Summarized from public sources; check the original articles before acting on it.